"ファイザー" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonIs Pfizer Inc. (PFE) the Best Large-Cap Value Stock to Buy as the Recession Hits? - Yahoo Finance
Is Pfizer Inc. (PFE) the Best Large-Cap Value Stock to Buy as the Recession Hits? Yahoo Finance
RSV shots from GSK, Pfizer get potential boost from broadened ACIP guidance - Fierce Pharma
RSV shots from GSK, Pfizer get potential boost from broadened ACIP guidance Fierce Pharma
Novavax says its COVID vaccine produces fewer, milder reactions than Pfizer version - CIDRAP
Novavax says its COVID vaccine produces fewer, milder reactions than Pfizer version CIDRAP
ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO - Business Wire
ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO Business Wire
Pfizer ends development of potential pill obesity treatment - CNN
What You Need to Know Ahead of Pfizer's Earnings Release - Nasdaq
What You Need to Know Ahead of Pfizer's Earnings Release Nasdaq
Tariff Turmoil, FDA’s Future, Pfizer’s Obesity Setback and CEO Salaries Revealed - BioSpace
Tariff Turmoil, FDA’s Future, Pfizer’s Obesity Setback and CEO Salaries Revealed BioSpace
Pfizer: Tasty 7% Yield (NYSE:PFE) - Seeking Alpha
Pfizer: Tasty 7% Yield (NYSE:PFE) Seeking Alpha
Pfizer stops work on pill for obesity - Good Morning America
Pfizer stops work on pill for obesity Good Morning America
Pfizer (PFE) Laps the Stock Market: Here's Why - Yahoo Finance
Pfizer (PFE) Laps the Stock Market: Here's Why Yahoo Finance
Why Pfizer Stock Topped the Market on Tuesday - Yahoo Finance
Why Pfizer Stock Topped the Market on Tuesday Yahoo Finance
Pfizer: Risks Priced In, Buy The Exceptional Valuation And Yield - Seeking Alpha
Pfizer: Risks Priced In, Buy The Exceptional Valuation And Yield Seeking Alpha
Viking Therapeutics' VK2735 Candidate Likely Boosted By Pfizer's Woes (NASDAQ:VKTX) - Seeking Alpha
Viking Therapeutics' VK2735 Candidate Likely Boosted By Pfizer's Woes (NASDAQ:VKTX) Seeking Alpha
CDC's broader RSV recommendation could be boon for GSK, Pfizer - FirstWord Pharma
CDC's broader RSV recommendation could be boon for GSK, Pfizer FirstWord Pharma
Pfizer drops obesity pill development after liver injury report - Clinical Trials Arena
Pfizer drops obesity pill development after liver injury report Clinical Trials Arena
Pfizer ends development of weight-loss pill danuglipron - Reuters
Pfizer ends development of weight-loss pill danuglipron Reuters
Pfizer ends development of potential pill obesity treatment - AP News
Pfizer ends development of potential pill obesity treatment AP News
Safety worries spur Pfizer to drop another obesity pill - BioPharma Dive
Safety worries spur Pfizer to drop another obesity pill BioPharma Dive
Pfizer to discontinue its GLP-1 pill for obesity due to liver toxicity - statnews.com
Pfizer to discontinue its GLP-1 pill for obesity due to liver toxicity statnews.com
Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron - Business Wire
Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron Business Wire
Post-Pfizer dropout, Lilly Achieves GLP-1 win in phase III - BioWorld MedTech
Post-Pfizer dropout, Lilly Achieves GLP-1 win in phase III BioWorld MedTech
Pfizer Drops Lead Obesity Asset After Liver Safety Concerns, Overall Review - BioSpace
Pfizer Drops Lead Obesity Asset After Liver Safety Concerns, Overall Review BioSpace
Pfizer will end development of daily weight-loss pill after liver injury - Fox Business
Pfizer will end development of daily weight-loss pill after liver injury Fox Business
Pfizer Halts Development of Weight-Loss Pill - WSJ - WSJ
Pfizer Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk. - Barron's
Pfizer Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk. Barron's
Pfizer: Discontinuation of Obesity Drug Candidate Danuglipron Has No Effect on Our Valuation - Mo...
Pfizer: Discontinuation of Obesity Drug Candidate Danuglipron Has No Effect on Our Valuation Morningstar
Is Pfizer Inc. (PFE) Among the Best Dividend Paying Stocks According to Hedge Funds? - Yahoo Finance
Is Pfizer Inc. (PFE) Among the Best Dividend Paying Stocks According to Hedge Funds? Yahoo Finance
Pfizer Inc. (PFE): “Dead Money… Close the Casket,” Says Jim Cramer - Yahoo Finance
Pfizer Inc. (PFE): “Dead Money… Close the Casket,” Says Jim Cramer Yahoo Finance
Pfizer discontinues its experimental GLP-1 pill - statnews.com
Pfizer discontinues its experimental GLP-1 pill statnews.com
Pfizer axes oral GLP-1 asset, blowing hole in obesity plan - Fierce Biotech
Pfizer axes oral GLP-1 asset, blowing hole in obesity plan Fierce Biotech
Pfizer Halts Obesity Pill Development Amid Safety Concerns - Yahoo Finance
Pfizer Halts Obesity Pill Development Amid Safety Concerns Yahoo Finance
Pfizer Halts Development of Obesity Drug After Patient Sustains 'Liver Injury' - Investopedia
Pfizer Halts Development of Obesity Drug After Patient Sustains 'Liver Injury' Investopedia
Pfizer discontinues GLP-1 pill trial, stock trades flat - Yahoo Finance
Pfizer discontinues GLP-1 pill trial, stock trades flat Yahoo Finance
Pfizer Abandons Obesity Pill After Liver Injury in Setback - Bloomberg
Pfizer Abandons Obesity Pill After Liver Injury in Setback Bloomberg
In a blow to its obesity pipeline, Pfizer drops oral drug after liver injury case - Endpoints News
In a blow to its obesity pipeline, Pfizer drops oral drug after liver injury case Endpoints News
Pfizer will end development of daily anti-obesity pill due to liver injury - The Hill
Pfizer will end development of daily anti-obesity pill due to liver injury The Hill
Pfizer hits setback in obesity drug race as GLP-1 trial halts - Yahoo Finance
Pfizer hits setback in obesity drug race as GLP-1 trial halts Yahoo Finance
Pfizer scraps daily weight loss pill after liver injury in one patient - CNBC
Pfizer scraps daily weight loss pill after liver injury in one patient CNBC
Pfizer Stops Work on Oral GLP-1 Obesity Drug After Safety Signal Surfaces in Clinical Trial - Med...
Pfizer Stops Work on Oral GLP-1 Obesity Drug After Safety Signal Surfaces in Clinical Trial MedCity News
Pfizer (NYSE:PFE) Discontinues Danuglipron Development After Safety Review in Study - Yahoo Finance
Pfizer (NYSE:PFE) Discontinues Danuglipron Development After Safety Review in Study Yahoo Finance
Pfizer ends development of weight-loss pill after patient's liver injury - upi.com
Pfizer ends development of weight-loss pill after patient's liver injury upi.com
Viking Rises as Pfizer’s Oral Obesity Med Falters - BioSpace
Why Pfizer's Obesity 'Stumble' Highlighted A Chief Rival — Again - Investor's Business Daily
Why Pfizer's Obesity 'Stumble' Highlighted A Chief Rival — Again Investor's Business Daily
Pfizer, Nvidia, Intel: Stocks in 30 - Yahoo Finance
Pfizer, Nvidia, Intel: Stocks in 30 Yahoo Finance
Pharmalittle: We're reading about Pfizer halting GLP-1 work, FDA use of contractors, and more - s...
Pharmalittle: We're reading about Pfizer halting GLP-1 work, FDA use of contractors, and more statnews.com
Pfizer ends development of pill to treat obesity after injury reported during trial - LiveNOW fro...
Pfizer ends development of pill to treat obesity after injury reported during trial LiveNOW from FOX
Pfizer Stock: This Falling Knife Keeps Going Lower And Lower (NYSE:PFE) - Seeking Alpha
Pfizer Stock: This Falling Knife Keeps Going Lower And Lower (NYSE:PFE) Seeking Alpha
Pfizer's obesity ambitions suffer blow as danuglipron development scrapped - FirstWord Pharma
Pfizer's obesity ambitions suffer blow as danuglipron development scrapped FirstWord Pharma
Pfizer Ends Testing of Obesity Pill After Possible Liver Injury - Physician's Weekly
Pfizer Ends Testing of Obesity Pill After Possible Liver Injury Physician's Weekly
What's Pfizer's next move after shelving its oral obesity drug danuglipron? - Endpoints News
What's Pfizer's next move after shelving its oral obesity drug danuglipron? Endpoints News
Pfizer to halt development of closely watched weight-loss drug - Financial Times
Pfizer to halt development of closely watched weight-loss drug Financial Times
Gaithersburg-Based Novavax’s COVID-19 Vaccine Shows Lower Side Effects Than Pfizer-BioNTech - The...
Gaithersburg-Based Novavax’s COVID-19 Vaccine Shows Lower Side Effects Than Pfizer-BioNTech The MoCo Show -
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults ...
Pfizer halts development of weight loss pill after liver injury report - WJLA
Pfizer halts development of weight loss pill after liver injury report WJLA
Why Pfizer Stock Topped the Market on Tuesday - The Motley Fool
Why Pfizer Stock Topped the Market on Tuesday The Motley Fool
Pfizer (NYSE:PFE) Gets CDC Recommendation to Expand ABRYSVO Vaccine Use for RSV Prevention - Yaho...
Pfizer (NYSE:PFE) Gets CDC Recommendation to Expand ABRYSVO Vaccine Use for RSV Prevention Yahoo Home
Obesity Drug Developers Rise on M&A Hopes After Pfizer Setback - Bloomberg
Obesity Drug Developers Rise on M&A Hopes After Pfizer Setback Bloomberg
Pfizer Discontinues Development Of Danuglipron - Nasdaq
Pfizer Awarded Diamond Resiliency Badge for Supply Chain Excellence - Pfizer
Pfizer Awarded Diamond Resiliency Badge for Supply Chain Excellence Pfizer
Pfizer just had a big setback in its race for an Ozempic competitor - Quartz
Pfizer just had a big setback in its race for an Ozempic competitor Quartz
Pfizer, GSK to gain as CDC ACIP votes for RSV shots (NYSE:PFE) - Seeking Alpha
Pfizer, GSK to gain as CDC ACIP votes for RSV shots (NYSE:PFE) Seeking Alpha
Pfizer stops work on potential obesity pill over patient liver injury - Euronews.com
Pfizer stops work on potential obesity pill over patient liver injury Euronews.com
Henlius In David Versus Goliath Race With Pfizer For First PD-L1 ADC - insights.citeline.com
Henlius In David Versus Goliath Race With Pfizer For First PD-L1 ADC insights.citeline.com
Pfizer abandons obesity pill after liver injury in setback - Crain's New York Business
Pfizer abandons obesity pill after liver injury in setback Crain's New York Business
Pfizer stock slips after dropping weight loss drug (PFE:NYSE) - Seeking Alpha
Pfizer stock slips after dropping weight loss drug (PFE:NYSE) Seeking Alpha
Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight Loss Pill? - The Motley Fool
Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight Loss Pill? The Motley Fool
Pfizer ends development of potential pill obesity treatment - WHNT.com
Pfizer ends development of potential pill obesity treatment WHNT.com
Blackstone Hires Former Pfizer Scientist to Find Blockbusters - Bloomberg
Blackstone Hires Former Pfizer Scientist to Find Blockbusters Bloomberg
Pfizer Abandons Obesity Pill After Trial Liver Injury - Yahoo Finance
Pfizer Abandons Obesity Pill After Trial Liver Injury Yahoo Finance
Pfizer (PFE) Advances But Underperforms Market: Key Facts - Yahoo Finance
Pfizer (PFE) Advances But Underperforms Market: Key Facts Yahoo Finance
Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Poten...
7 major R&D developments this week: Tariff uncertainty persists, Pfizer sells campus, Scania acqu...
Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip? - Yahoo Finance
Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip? Yahoo Finance
Pfizer’s Danuglipron Is Done, Sparking M&A Speculation - insights.citeline.com
Pfizer’s Danuglipron Is Done, Sparking M&A Speculation insights.citeline.com
Pfizer, Flagship tap Valo Health for autoimmune offshoot of multibillion-dollar collab - Fierce B...
Pfizer, Flagship tap Valo Health for autoimmune offshoot of multibillion-dollar collab Fierce Biotech
As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here to stay - Fierce...
As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here to stay Fierce Pharma
Pfizer pulls plug on weight-loss pill, citing trial concerns - Investing.com
Pfizer pulls plug on weight-loss pill, citing trial concerns Investing.com
UC San Diego Moores Cancer Center Receives $1M Donation from Pfizer for Early Cancer Detection - ...
UC San Diego Moores Cancer Center Receives $1M Donation from Pfizer for Early Cancer Detection UC San Diego Today
Pfizer Discontinues Development of Weight-Loss Pill Danuglipron Following Liver Injury Incident -...
Pfizer Discontinues Development of Weight-Loss Pill Danuglipron Following Liver Injury Incident Deccan Herald
Pfizer will end development of weight-loss pill over fears about its impact to the liver - The In...
Pfizer will end development of weight-loss pill over fears about its impact to the liver The Independent
Viking stock on a tear after Pfizer setback (VKTX:NASDAQ) - Seeking Alpha
Viking stock on a tear after Pfizer setback (VKTX:NASDAQ) Seeking Alpha
Pfizer: A Strategy For A Chaotic Implied Volatility - Seeking Alpha
Pfizer: A Strategy For A Chaotic Implied Volatility Seeking Alpha
Pfizer Takes Over SXSW’s Podcasting Lounge for the Second Year in a Row - Pfizer
Pfizer Takes Over SXSW’s Podcasting Lounge for the Second Year in a Row Pfizer
Pfizer shakes up R&D footprint in San Diego with $255M site sale, 56 layoffs - Fierce Biotech
Pfizer shakes up R&D footprint in San Diego with $255M site sale, 56 layoffs Fierce Biotech
Pfizer’s Wall Street critic-turned-executive digs into the company’s problems, obesity plans - st...
Pfizer’s Wall Street critic-turned-executive digs into the company’s problems, obesity plans statnews.com
Will Pfizer approach Viking Therapeutics with a buyout proposal? - TradingView
Will Pfizer approach Viking Therapeutics with a buyout proposal? TradingView
Join Pfizer in the Fight Against Cancer - Pfizer
Living with Colon Cancer: A Pfizer Colleague’s Story - Pfizer
Pfizer School of Science Marks Two Years of Impacting Communities - Pfizer
Pfizer School of Science Marks Two Years of Impacting Communities Pfizer
Pfizer Ends Development of Potential Pill Obesity Treatment - GV Wire
Pfizer Ends Development of Potential Pill Obesity Treatment GV Wire
Attorney General Bonta Announces Nearly $60 Million Settlement Against Pfizer-Owned Pharmaceutica...
Attorney General Bonta Announces Nearly $60 Million Settlement Against Pfizer-Owned Pharmaceutical Holding Company, Biohaven State of California - Department of Justice (.gov)
Pfizer Recognized as “2024 Corporate Partner of the Year” by American Cancer Society - Pfizer
Pfizer Recognized as “2024 Corporate Partner of the Year” by American Cancer Society Pfizer
Novavax Covid Vaccine Shows Milder Side Effects Than Pfizer-BioNTech's Shot: Study - Benzinga
Novavax Covid Vaccine Shows Milder Side Effects Than Pfizer-BioNTech's Shot: Study Benzinga
Pfizer Looks Back at 2024 in the Annual Review - Pfizer
Pfizer axes controversial medication amid liver cancer fears - Daily Mail
Pfizer axes controversial medication amid liver cancer fears Daily Mail
GSK and Pfizer reach licensing deal over RSV vaccine - JUVE Patent
GSK and Pfizer reach licensing deal over RSV vaccine JUVE Patent
175 Days of Good - Pfizer
175 Days of Good Pfizer
Pfizer ends pill development for obesity treatment - The Iola Register
Pfizer ends pill development for obesity treatment The Iola Register
Bernstein reiterates Pfizer stock with $30 target post-drug axe - Investing.com
Bernstein reiterates Pfizer stock with $30 target post-drug axe Investing.com
Pharmaceutical giant halts pill over concerning side effects - The Nightly
Pharmaceutical giant halts pill over concerning side effects The Nightly